Amphivena Therapeutics
San Francisco, US · Founded 2012 · Delaware corporation · 2 known investors
Biotech
Founders & leadership
JG
Jeanmarie GuenotNamed on SEC filing
FF
Florian FischerNamed on SEC filing
Board
LE
Investors · 2
Reported raises · per SEC filings
Form D private placements$65.2M disclosed across 3 rounds · 2013–2018
▶$38.7MraisedDec 2018 · 15 investors · Other Health CareRule 506(b)
▶$38.7MraisedDec 2018 · 15 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Luke EvninDirector
- Peter Van VasselaerExecutive Officer, Director
- Mark McDadeDirector
- Jeanmarie GuenotExecutive Officer, Director
- Eric MoessingerDirector
- Christian RichardDirector
- Offering amount
- $50M
- Amount sold
- $38.7M
- First sale
- Dec 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7MraisedJul 2017 · 2 investors · BiotechnologyRule 506(b)
▶$7MraisedJul 2017 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Luke EvninDirector
- Jeanmarie GuenotExecutive Officer, Director
- Christian RichardDirector
- Vinay BhaskarDirector
- Florian FischerDirector
- Offering amount
- $7M
- Amount sold
- $7M
- First sale
- Jul 2017
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$19.5MraisedJun 2017 · 4 investors · BiotechnologyRule 506(b)
▶$19.5MraisedJun 2017 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Luke EvninDirector
- Jeanmarie GuenotExecutive Officer, Director
- Florian FischerDirector
- Offering amount
- $19.5M
- Amount sold
- $19.5M
- Proceeds to insiders
- $100K
- First sale
- Jul 2013
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Amphivena Therapeutics's investors?
- Amphivena Therapeutics's investors include MPM BioImpact, Qiming Healthcare.
- How much funding has Amphivena Therapeutics raised?
- Amphivena Therapeutics has disclosed $65.2M raised across 3 rounds.
- Where is Amphivena Therapeutics headquartered?
- Amphivena Therapeutics is headquartered in San Francisco, US.